Clinical Trial Update: Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (APPLE-COPD: ICON 2) evaluating antiplatelet therapy to prevent cardiovascular disease in patients with COPD; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED